Evidence map›Paper›PMID 21868708›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2011

Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice.

Andrea Callegari, Yuhua Liu, Collin C White, Alan Chait, Peter Gough, Elaine W Raines, David Cox, Terrance J Kavanagh, Michael E Rosenfeld

Open access · greenAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. S-glutathionylation in monocyte and macrophage (dys)function.International journal of molecular sciences · 2013
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Andrea CallegariDepartment of Pathology, University of Washington, Seattle, WA 98195, USA.
Yuhua Liu
Collin C White
Alan Chait
Peter Gough
Elaine W Raines
David Cox
Terrance J Kavanagh
Michael E Rosenfeld
GlaxoSmithKline (United States) · US

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI ALI SHOJAIE · 1995 to 2026
$42.5M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
VLA-4 and VCAM-1 in Advanced AtherosclerosisP01HL018645 · NHLBI · UNIVERSITY OF WASHINGTON · PI CHAIT, ALAN · 1985 to 2010
$23.9M
Serum Amyloid and Inflammation in AtherogenesisP01HL030086 · NHLBI · UNIVERSITY OF WASHINGTON · PI HEINECKE, JAY W · 1985 to 2009
$14.7M
Environmetal Pathology/Toxicology Training ProgramT32ES007032 · NIEHS · UNIVERSITY OF WASHINGTON · PI FAUSTMAN, ELAINE M, ROSENFELD, MICHAEL E · 1985 to 2023
$10.7M
MMP-9 AS A PROINFLAMMATORY REGULATOR IN ATHEROGENESISR01HL081795 · NHLBI · UNIVERSITY OF WASHINGTON · PI RAINES, ELAINE W · 2005 to 2010
$2.6M
Glutathione, macrophages and unstable atherosclerosisR01HL076748 · NHLBI · UNIVERSITY OF WASHINGTON · PI ROSENFELD, MICHAEL E · 2004 to 2007
$1.5M
Glutamate-L-cysteine ligase expression and liver injuryR01ES010849 · NIEHS · UNIVERSITY OF WASHINGTON · PI KAVANAGH, TERRANCE J · 2002 to 2004
$783k
NHLBI NIH HHS P01 HL018645NHLBI NIH HHS P01 HL030086NHLBI NIH HHS R01 HL076748NHLBI NIH HHS R01 HL081795NHLBI NIH HHS R01-HL30086NHLBI NIH HHS R01-HL6748NIDDK NIH HHS P30 DK035816NIEHS NIH HHS P30 ES007033NIEHS NIH HHS R01 ES010849NIEHS NIH HHS R01-ES10849NIEHS NIH HHS T32 ES007032
6 · The paper itself

Abstract

objectiveGlutamate-cysteine ligase (GCL) is the rate-limiting step in glutathione synthesis. The enzyme is a heterodimer composed of a catalytic subunit, GCLC, and a modifier subunit, GCLM. We generated apolipoprotein E (apoE)-/- mice deficient in GCLM (apoE-/-/Gclm-/-) and transgenic mice that overexpress GCLC specifically in macrophages (apoE-/-/Gclc-Tg) to test the hypothesis that significantly altering the availability of glutathione has a measurable impact on both the initiation and progression of atherosclerosis. METHODS AND

resultsAtherosclerotic plaque size and composition were measured in the innominate artery in chow-fed male and female mice at 20, 30, 40, and 50 weeks of age and in the aortic sinus at 40 and 50 weeks of age. The apoE-/-/Gclm-/- mice more rapidly developed complex lesions, whereas the apoE-/-/Gclc-Tg mice had reduced lesion development compared with the littermate apoE-/- control mice. Transplantation of bone marrow from the apoE-/-/Gclm-/- and apoE-/-/Gclc-Tg mice into apoE-/- mice with established lesions also stimulated or inhibited further lesion development at 30 weeks posttransplant.

conclusionGain and loss of function in the capacity to synthesize glutathione especially in macrophages has reciprocal effects on the initiation and progression of atherosclerosis at multiple sites in apoE-/- mice.

Indexed as

AnimalsApolipoproteins EAtherosclerosisBrachiocephalic TrunkDisease Models, AnimalDisease ProgressionFemaleGlutamate-Cysteine LigaseGlutathioneLipidsMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicApolipoproteins EGCLM protein, mouseGlutamate-Cysteine LigaseGlutathioneLipids

Identifiers

PMID21868708
PMCPMC3415243
OpenAlexW2087143652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.